Business · 18/04/2012Updated: 10/17/2026 · 1 min read
FDA Corrects Notice on KEPIVANCE Patent Extension Review Period
Summary
The FDA is correcting a notice regarding KEPIVANCE, a biologics license application, after citing an incorrect statute in the original document, which was published in the Federal Register on April 2, 2007.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →